vs
Clearfield, Inc.（CLFD）与PRECISION BIOSCIENCES INC（DTIL）财务数据对比。点击上方公司名可切换其他公司
Clearfield, Inc.的季度营收约是PRECISION BIOSCIENCES INC的1.0倍（$34.3M vs $34.2M），PRECISION BIOSCIENCES INC净利率更高（58.9% vs -1.8%，领先60.6%），PRECISION BIOSCIENCES INC同比增速更快（5261.1% vs -3.2%），Clearfield, Inc.自由现金流更多（$-2.4M vs $-11.3M），过去两年PRECISION BIOSCIENCES INC的营收复合增速更高（39.5% vs -3.5%）
Clearfield, Inc.总部位于美国明尼苏达州明尼阿波利斯市，是一家专注于光纤产品研发生产的企业，其产品主要应用于光纤通信网络建设领域，为通信基础设施部署提供相关硬件支撑。
精准生物科学公司是一家上市的美国临床阶段基因编辑企业，总部位于北卡罗来纳州达勒姆，成立于2006年。该公司依托自主研发的ARCUS基因组编辑平台，专注于开发体内和体外两类基因编辑疗法。
CLFD vs DTIL — 直观对比
营收规模更大
CLFD
是对方的1.0倍
$34.2M
营收增速更快
DTIL
高出5264.3%
-3.2%
净利率更高
DTIL
高出60.6%
-1.8%
自由现金流更多
CLFD
多$8.8M
$-11.3M
两年增速更快
DTIL
近两年复合增速
-3.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.3M | $34.2M |
| 净利润 | $-614.0K | $20.1M |
| 毛利率 | 33.2% | — |
| 营业利润率 | -5.3% | 36.6% |
| 净利率 | -1.8% | 58.9% |
| 营收同比 | -3.2% | 5261.1% |
| 净利润同比 | 67.8% | 213.5% |
| 每股收益（稀释后） | $-0.04 | $2.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLFDDTIL
| Q4 25 | $34.3M | $34.2M | ||
| Q3 25 | $23.4M | $13.0K | ||
| Q2 25 | $49.9M | $18.0K | ||
| Q1 25 | $47.2M | $29.0K | ||
| Q4 24 | $29.7M | $638.0K | ||
| Q3 24 | $5.6M | $576.0K | ||
| Q2 24 | $48.8M | $49.9M | ||
| Q1 24 | $36.9M | $17.6M |
净利润CLFDDTIL
| Q4 25 | $-614.0K | $20.1M | ||
| Q3 25 | $-9.1M | $-21.8M | ||
| Q2 25 | $1.6M | $-23.5M | ||
| Q1 25 | $1.3M | $-20.6M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | — | $-16.4M | ||
| Q2 24 | $-447.0K | $32.7M | ||
| Q1 24 | $-5.9M | $8.6M |
毛利率CLFDDTIL
| Q4 25 | 33.2% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 30.5% | — | ||
| Q1 25 | 30.1% | — | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 21.9% | — | ||
| Q1 24 | 7.7% | — |
营业利润率CLFDDTIL
| Q4 25 | -5.3% | 36.6% | ||
| Q3 25 | 10.3% | -158976.9% | ||
| Q2 25 | 3.0% | -121538.9% | ||
| Q1 25 | 0.6% | -76248.3% | ||
| Q4 24 | -6.9% | — | ||
| Q3 24 | — | -3693.6% | ||
| Q2 24 | -4.7% | 48.4% | ||
| Q1 24 | -26.4% | -23.8% |
净利率CLFDDTIL
| Q4 25 | -1.8% | 58.9% | ||
| Q3 25 | -38.8% | -167476.9% | ||
| Q2 25 | 3.2% | -130666.7% | ||
| Q1 25 | 2.8% | -70913.8% | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | — | -2851.6% | ||
| Q2 24 | -0.9% | 65.6% | ||
| Q1 24 | -16.0% | 48.8% |
每股收益（稀释后）CLFDDTIL
| Q4 25 | $-0.04 | $2.62 | ||
| Q3 25 | $-0.65 | $-1.84 | ||
| Q2 25 | $0.11 | $-2.13 | ||
| Q1 25 | $0.09 | $-2.21 | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | — | $-2.25 | ||
| Q2 24 | $-0.04 | $4.67 | ||
| Q1 24 | $-0.40 | $1.70 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $96.4M | $115.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $249.7M | $92.2M |
| 总资产 | $268.1M | $154.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLFDDTIL
| Q4 25 | $96.4M | $115.6M | ||
| Q3 25 | $106.0M | $44.9M | ||
| Q2 25 | $117.2M | $62.2M | ||
| Q1 25 | $112.0M | $77.2M | ||
| Q4 24 | $113.0M | $86.3M | ||
| Q3 24 | $129.0M | $101.2M | ||
| Q2 24 | $123.8M | $123.6M | ||
| Q1 24 | $142.9M | $137.8M |
总债务CLFDDTIL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
股东权益CLFDDTIL
| Q4 25 | $249.7M | $92.2M | ||
| Q3 25 | $256.2M | $16.6M | ||
| Q2 25 | $264.5M | $34.1M | ||
| Q1 25 | $265.9M | $49.3M | ||
| Q4 24 | $267.4M | $56.4M | ||
| Q3 24 | $275.8M | $64.9M | ||
| Q2 24 | $274.6M | $74.7M | ||
| Q1 24 | $279.2M | $37.2M |
总资产CLFDDTIL
| Q4 25 | $268.1M | $154.4M | ||
| Q3 25 | $306.2M | $93.5M | ||
| Q2 25 | $314.7M | $108.9M | ||
| Q1 25 | $310.9M | $124.4M | ||
| Q4 24 | $303.2M | $136.4M | ||
| Q3 24 | $315.3M | $153.3M | ||
| Q2 24 | $318.1M | $165.8M | ||
| Q1 24 | $315.4M | $184.7M |
负债/权益比CLFDDTIL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.4M | $-11.3M |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | $-11.3M |
| 自由现金流率自由现金流/营收 | -7.1% | -32.9% |
| 资本支出强度资本支出/营收 | 2.9% | 0.1% |
| 现金转化率经营现金流/净利润 | — | -0.56× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLFDDTIL
| Q4 25 | $-1.4M | $-11.3M | ||
| Q3 25 | — | $-15.3M | ||
| Q2 25 | $7.9M | $-20.3M | ||
| Q1 25 | $3.0M | $-19.1M | ||
| Q4 24 | $7.2M | $-58.4M | ||
| Q3 24 | $22.2M | $-5.9M | ||
| Q2 24 | $4.0M | $-14.9M | ||
| Q1 24 | $-5.7M | $-19.0M |
自由现金流CLFDDTIL
| Q4 25 | $-2.4M | $-11.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | $7.5M | $-20.3M | ||
| Q1 25 | $654.0K | $-19.1M | ||
| Q4 24 | $5.1M | $-58.7M | ||
| Q3 24 | $18.2M | $-6.0M | ||
| Q2 24 | $2.8M | $-14.9M | ||
| Q1 24 | $-7.7M | $-19.1M |
自由现金流率CLFDDTIL
| Q4 25 | -7.1% | -32.9% | ||
| Q3 25 | — | — | ||
| Q2 25 | 15.1% | -112627.8% | ||
| Q1 25 | 1.4% | -65917.2% | ||
| Q4 24 | 17.1% | -9199.8% | ||
| Q3 24 | 323.0% | -1033.2% | ||
| Q2 24 | 5.8% | -29.9% | ||
| Q1 24 | -20.8% | -108.4% |
资本支出强度CLFDDTIL
| Q4 25 | 2.9% | 0.1% | ||
| Q3 25 | 2.0% | 0.0% | ||
| Q2 25 | 0.8% | 11.1% | ||
| Q1 25 | 5.1% | 220.7% | ||
| Q4 24 | 7.0% | 39.2% | ||
| Q3 24 | 71.4% | 6.8% | ||
| Q2 24 | 2.5% | 0.1% | ||
| Q1 24 | 5.3% | 0.5% |
现金转化率CLFDDTIL
| Q4 25 | — | -0.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.45× | ||
| Q1 24 | — | -2.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
